Zobrazeno 1 - 10
of 156
pro vyhledávání: '"B, Comet"'
Autor:
Thomas Lacornerie, B. Comet, Eric Lartigau, Mathieu Faivre-Pierret, Sylvain Dewas, Andrew Kramar, Jean-Louis Lefebvre, M. Degardin, Bernard Coche-Dequeant
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 84:203-209
Purpose Normal tissues tolerance limits the use of reirradiation for recurrent head-and-neck cancers (HNC). Stereotactic body radiotherapy (SBRT) could offer precise irradiation while sparing healthy tissues. Results of a feasibility study using SBRT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125bb51c85f786715f14eee736b08175
https://doi.org/10.1016/j.ijrobp.2011.11.054
https://doi.org/10.1016/j.ijrobp.2011.11.054
Publikováno v:
Bulletin du Cancer. 98:1477-1488
Recurrences or second primary head and neck cancers meant, for a long time, therapeutic dead ends. Surgery was the standard treatment, but could only be achieved in 25% of the patients. The GETTEC-GORTEC (99-01) randomized trial showed that radiochem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6e80166751d2d04cc24a56443d0b1c2
https://doi.org/10.1684/bdc.2011.1505
https://doi.org/10.1684/bdc.2011.1505
Autor:
Eric Lartigau, B. Comet
Publikováno v:
Cancer/Radiothérapie. 14:416-420
Locally advanced head and neck cancers are primarily treated by a multimodal approach, including a combination of surgery, radiotherapy and chemotherapy. However, local relapse rate in a previously irradiated area remains high. Reirradiation for a no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::375e47bda028892f98374e70ac371396
https://doi.org/10.1016/j.canrad.2010.06.018
https://doi.org/10.1016/j.canrad.2010.06.018
Autor:
Youlia M. Kirova, Catherine Delva, Bruno Cutuli, Julien Edeline, Hervé Mignotte, Yazid Belkacemi, Pascale Romestaing, Claire Lemanski, C. Cohen-Solal Le-Nir, B. De Lafontan, Z. Gaci, D. Serin, C. Tunon de Lara, Frédérique Penault-Llorca, M. Zoubir, B. Comet, P. Maingon
Publikováno v:
Critical Reviews in Oncology/Hematology. 73:246-254
Infiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic factors in a large French cohort.Four hundred and eighty-nine patients were collected from 1990 to 2005. Median a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb6c0bc48845de67c3b82eeedc7669fd
https://doi.org/10.1016/j.critrevonc.2009.04.002
https://doi.org/10.1016/j.critrevonc.2009.04.002
Autor:
M Leblanc-Onfroy, Jean-Michel Hannoun-Levi, Yazid Belkacemi, B Delalande, David Azria, Hugo Marsiglia, J.-B. Dubois, S Villette, B Comet
Publikováno v:
Cancer/Radiothérapie. 11:287-295
Whole breast irradiation delivering an equivalent dose of 50 Gy in 5 weeks, followed by a 10 to 16 Gy-boost to the tumor bed is the standard of care after breast-conserving surgery for early-breast cancer. Accelerated partial breast irradiation (APBI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea125c110ab42d3688e2daf8600d67e9
https://doi.org/10.1016/j.canrad.2007.09.145
https://doi.org/10.1016/j.canrad.2007.09.145
Publikováno v:
Oncologie. 9:458-465
Les therapies ciblees prennent de plus en plus de place dans l’arsenal therapeutique de nombreux cancers. Leur association avec la chimiotherapie s’est revelee efficace avec des profils de toxicites differents. Avec l’allongement de la survie d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9b241ac44a4dfe5dc2f29f47daed9f8
https://doi.org/10.1007/s10269-007-0682-5
https://doi.org/10.1007/s10269-007-0682-5
Publikováno v:
Cancer/Radiothérapie. 10:124-133
During the last half of century considerable research on radiosensitivity biomarkers has been published. However, to date there is no non-invasive marker of cellular radiosensitivity identified for clinical routinely use. In this review, the main fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3742d706984e35d57babaa30c7ccfc81
https://doi.org/10.1016/j.canrad.2005.09.022
https://doi.org/10.1016/j.canrad.2005.09.022
Publikováno v:
Current opinion in otolaryngologyhead and neck surgery. 20(2)
PURPOSE OF REVIEW The standard treatment for recurrent or second primary head and neck cancers is surgery which can only be performed in 25% of the patients. For inoperable patients, three options can be discussed: supportive care only, chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f957950058a91238fe04615127739487
https://pubmed.ncbi.nlm.nih.gov/22249172
https://pubmed.ncbi.nlm.nih.gov/22249172
Autor:
B, Comet, E, Lartigau
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 14(6-7)
Locally advanced head and neck cancers are primarily treated by a multimodal approach, including a combination of surgery, radiotherapy and chemotherapy. However, local relapse rate in a previously irradiated area remains high. Reirradiation for a no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28834718857cd00f70c1f50fddea6474
https://pubmed.ncbi.nlm.nih.gov/20810299
https://pubmed.ncbi.nlm.nih.gov/20810299
Publikováno v:
Adv Space Res
Adv Space Res, 2010, 46 (7), pp.831-839. ⟨10.1016/j.asr.2010.05.023⟩
Adv Space Res, 2010, 46 (7), pp.831-839. ⟨10.1016/j.asr.2010.05.023⟩
International audience; This paper reviews the medical operations performed on six European astronauts during seven space missions on board the space station Mir. These missions took place between November 1988 and August 1999, and their duration ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2af5cbd3947642806aaf9a015a8e9e4
https://hal.archives-ouvertes.fr/hal-00532589
https://hal.archives-ouvertes.fr/hal-00532589
